Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation
[Display omitted] PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin–proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechani...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 107; pp. 129778 - 129782 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
OXFORD
Elsevier Ltd
15.07.2024
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [Display omitted]
PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin–proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON-OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light-induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery. |
---|---|
AbstractList | PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin -proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC 's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON -OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light -induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery. PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin-proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON-OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light-induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery.PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin-proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON-OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light-induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery. [Display omitted] PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin–proteasome system. These molecules catalytically degrade target proteins and sustainably inhibit their function. Therefore, PROTAC's unique mechanism of action is not only beneficial in medicine but also serves as a valuable tool for molecular biological analysis in fields like chemical biology, biochemistry, and drug discovery. This study presents a novel turn-off (ON-OFF) type PROTAC development strategy utilizing a photocleavable linker. The inclusion of this linker enables temporal control of the degradation activity targeting BRD4 protein upon UV light exposure. PROTAC-2 demonstrated the most potent degradation activity against BRD4 among the other synthesized PROTACs with varying linker lengths. The UV light-induced cleavage of PROTAC-2 was confirmed, leading to a reduction in its BRD4 degradation activity. Notably, this study introduces a novel linker capable of nullifying degradation activity of PROTACs which is activated by light irradiation. These findings offer a promising strategy for the development of turn-off type PROTACs, providing enhanced temporal control over protein degradation. The approach holds significant potential for applications in molecular function studies and drug discovery. |
ArticleNumber | 129778 |
Author | Yokoo, Hidetomo Demizu, Yosuke Xu, Hanqiao Inoue, Takao Ohoka, Nobumichi |
Author_xml | – sequence: 1 givenname: Hanqiao surname: Xu fullname: Xu, Hanqiao organization: Graduate School of Medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan – sequence: 2 givenname: Nobumichi surname: Ohoka fullname: Ohoka, Nobumichi email: n-ohoka@nihs.go.jp organization: Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan – sequence: 3 givenname: Takao surname: Inoue fullname: Inoue, Takao organization: Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan – sequence: 4 givenname: Hidetomo surname: Yokoo fullname: Yokoo, Hidetomo email: yokoo@nihs.go.jp organization: Division of Organic Chemistry, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan – sequence: 5 givenname: Yosuke orcidid: 0000-0001-7521-4861 surname: Demizu fullname: Demizu, Yosuke email: demizu@nihs.go.jp organization: Graduate School of Medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38702019$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkF1rFDEUQIO02G31D_gg8yjIbPM1k4n4sgy2CoUWqSC-hEzmZp1lJlmTTMV_b9ZZ-1ialwvhnMvlnKMT5x0g9IbgNcGkvtytu8mMa4opXxMqhWheoBXhNS8Zx9UJWmFZ47KR_PsZOo9xhzHhmPOX6Iw1AlNM5Ar9uPvpky8DbOdRJ-iLu6-395s2fig2hfMPMBbJ-7GwPhQJpr0PeiyMdynkT2-LpMMWDto--ASDK3rYBt3rNHj3Cp1aPUZ4fZwX6NvVp_v2c3lze_2l3dyUhgmWSg4NowJq0tW81zXrrOVGSlMBt0KzimBrRUMEZXWltRTMEspl14A0Vuq-Yxfo3bI33_BrhpjUNEQD46gd-DkqhissmZREZvTtEZ27CXq1D8Okwx_1v0cG6AKY4GMMYB8RgtUhutqpQ3R1iK6W6FlqFuk3dN5GM4Az8Cjm6jTvF6TB-ZF2SP_qtH52Kavvn69m-uNCQ875MEBQR6MfApikej88dedfw_OqiA |
Cites_doi | 10.1039/d2cs00193d 10.1021/acscentsci.9b00713 10.1002/cmdc.202300530 10.1039/c5py00562k 10.1016/j.molcel.2021.01.023 10.1039/d2cc03092f 10.1038/s41589-018-0055-y 10.1021/jacs.9b12718 10.1016/j.molcel.2017.06.004 10.1016/j.cbpa.2022.102148 10.1007/s40265-013-0047-x 10.1126/sciadv.aay5154 10.1016/j.scib.2023.04.028 10.1002/anie.202306824 10.3389/fcell.2021.678077 10.1021/acs.jmedchem.9b02058 10.1007/s13238-020-00732-8 10.1021/acs.jcim.8b00872 10.1039/d2cc03367d 10.1021/acs.jcim.0c00897 10.31635/ccschem.022.202101529 10.1039/d0cc00523a 10.1039/D0CC00523A 10.1039/D2CS00193D 10.1039/D2CC03092F 10.1039/D2CC03367D 10.1039/C5PY00562K |
ContentType | Journal Article |
Copyright | 2024 Elsevier Ltd Copyright © 2024 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2024 Elsevier Ltd – notice: Copyright © 2024 Elsevier Ltd. All rights reserved. |
DBID | 17B 1KM BLEPL DTL EGQ AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.bmcl.2024.129778 |
DatabaseName | Web of Knowledge Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | Web of Science CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | Web of Science PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Chemistry |
EISSN | 1464-3405 |
ExternalDocumentID | 38702019 10_1016_j_bmcl_2024_129778 001238771800001 S0960894X2400180X |
Genre | Journal Article |
GrantInformation_xml | – fundername: Grants-in-Aid for Scientific Research; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research (KAKENHI) grantid: 21K06490; 22K15257 – fundername: Japan Society for the Promotion of Science (KAKENHI); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research (KAKENHI) grantid: JP21K05320; JP23H04926; JP22K15257; JP18K06567; JP21K06490 – fundername: AMED grantid: 23fk0210110; 23fk0310506; 23ak0101186; 23fk0310504 – fundername: Takeda Science Foundation; Takeda Science Foundation (TSF) – fundername: Kowa Life Science Foundation – fundername: JST, the establishment of university fellowships towards the creation of science technology innovation grantid: JPMJFS2140 – fundername: JST (ACT-X) grantid: JPMJAX222L |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AAXUO ABBQC ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABZDS ACDAQ ACGFS ACIUM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJSZI AKRWK ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 D0L EBS EFJIC EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SEW SPC SPCBC SSH SSK SSP SSU SSZ T5K YK3 ZMT ~02 ~G- 17B 1KM AATTM AAXKI AAYWO ACIEU ACVFH ADCNI AEIPS AEUPX AFJKZ AFPUW AGCQF AGRNS AIGII AIIUN AKBMS AKYEP ANKPU APXCP BLEPL DTL EFKBS GROUPED_WOS_WEB_OF_SCIENCE LZ2 M29 M2Z M34 .HR 53G 6TJ AAQXK AAYXX ABWVN ABXDB ACNNM ACRPL ADMUD ADNMO ADXHL AFFNX AGQPQ AGRDE AHHHB ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB G-2 HEA HMK HMO HMS HMT HVGLF HZ~ R2- SAE SCB SOC SPT WUQ XPP Y6R ZY4 NPM 7X8 |
ID | FETCH-LOGICAL-c373t-4e8327e61b64da63bff4c99c5e4f7a3510ff78172365aa973f1249b8e9cf9adb3 |
IEDL.DBID | .~1 |
ISICitedReferencesCount | 2 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=001238771800001 |
ISSN | 0960-894X 1464-3405 |
IngestDate | Mon Jul 21 09:50:06 EDT 2025 Mon Jul 21 06:05:00 EDT 2025 Thu Jul 03 08:46:09 EDT 2025 Tue Jul 22 04:47:47 EDT 2025 Fri Aug 29 16:13:57 EDT 2025 Sat Jun 01 15:40:37 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Turn-off type Chemical tool PROTAC Photocleavable linker Photo-caged group |
Language | English |
License | Copyright © 2024 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c373t-4e8327e61b64da63bff4c99c5e4f7a3510ff78172365aa973f1249b8e9cf9adb3 |
Notes | KAKEN ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7521-4861 |
PMID | 38702019 |
PQID | 3050939919 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | webofscience_primary_001238771800001 proquest_miscellaneous_3050939919 webofscience_primary_001238771800001CitationCount crossref_primary_10_1016_j_bmcl_2024_129778 elsevier_sciencedirect_doi_10_1016_j_bmcl_2024_129778 pubmed_primary_38702019 |
PublicationCentury | 2000 |
PublicationDate | 2024-07-15 |
PublicationDateYYYYMMDD | 2024-07-15 |
PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-15 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | OXFORD |
PublicationPlace_xml | – name: OXFORD – name: England |
PublicationTitle | Bioorganic & medicinal chemistry letters |
PublicationTitleAbbrev | BIOORG MED CHEM LETT |
PublicationTitleAlternate | Bioorg Med Chem Lett |
PublicationYear | 2024 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Drummond, Henry, Li, Williams (b0105) 2020; 60 Li, Crews (b0005) 2022; 51 Schwalm, Knapp (b0090) 2022; 68 An, Deng, Chi (b0040) 2023; 62 Kaiho-Soma, Akizuki, Igarashi (b0010) 2021; 81 Liang, Zheng, Luo, Cai, Mao, Wang (b0030) 2022; 4 Winter, Mayer, Buckley (b0080) 2017; 67 Kounde, Shchepinova, Saunders (b0065) 2020; 56 Zhang, Kounde, Mondal (b0050) 2022; 58 Hu, Shi, Thomas (b0095) 2015; 6 Liu, Chen, Ma (b0075) 2020; 6 Naro, Darrah, Deiters (b0060) 2020; 142 Drummond, Williams (b0100) 2019; 59 Gao, Zheng, Du (b0015) 2020; 11 Gao, Yang, Lei (b0035) 2023; 68 Pfaff, Samarasinghe, Crews, Carreira (b0045) 2019; 5 Liu, Peng, Wei (b0055) 2021; 9 Liu, Ren, Sun (b0025) 2022; 58 Zhao, Narjes (b0020) 2023; 18 Jin, Lu, Wang (b0070) 2020; 63 Elkinson, McCormack (b0085) 2013; 73 Nowak, DeAngelo, Buckley (b0110) 2018; 14 Liu, J (WOS:000680366500001) 2021; 9 Zhao, HT (WOS:001100700000001) 2023; 18 Liu, J (WOS:000514842000021) 2020; 6 Schwalm, MP (WOS:000800101400002) 2022; 68 Liang, CJ (WOS:000908427000015) 2022; 4 Jin, YH (WOS:000535279800017) 2020; 63 Drummond, ML (WOS:000586716900072) 2020; 60 Naro, Y (WOS:000512222700020) 2020; 142 Gao, HY (WOS:000535447000001) 2020; 11 Elkinson, S (WOS:000318574200008) 2013; 73 Hu, XR (WOS:000357163800013) 2015; 6 Drummond, ML (WOS:000465644500033) 2019; 59 Pfaff, P (WOS:000492698300011) 2019; 5 Nowak, RP (WOS:000435446600016) 2018; 14 Li, K (WOS:000807096700001) 2022; 51 Zhang, QS (WOS:000850258400001) 2022; 58 Gao, J (WOS:001019160200001) 2023; 68 Winter, GE (WOS:000404897300003) 2017; 67 Kaiho-Soma, A (WOS:000637214700010) 2021; 81 Kounde, CS (WOS:000536127800013) 2020; 56 Liu, HX (WOS:000842605800001) 2022; 58 An, KL (WOS:001048928600001) 2023; 62 Naro (10.1016/j.bmcl.2024.129778_b0060) 2020; 142 Nowak (10.1016/j.bmcl.2024.129778_b0110) 2018; 14 Schwalm (10.1016/j.bmcl.2024.129778_b0090) 2022; 68 Pfaff (10.1016/j.bmcl.2024.129778_b0045) 2019; 5 Liu (10.1016/j.bmcl.2024.129778_b0055) 2021; 9 Liu (10.1016/j.bmcl.2024.129778_b0025) 2022; 58 Gao (10.1016/j.bmcl.2024.129778_b0035) 2023; 68 Kounde (10.1016/j.bmcl.2024.129778_b0065) 2020; 56 Hu (10.1016/j.bmcl.2024.129778_b0095) 2015; 6 Kaiho-Soma (10.1016/j.bmcl.2024.129778_b0010) 2021; 81 Li (10.1016/j.bmcl.2024.129778_b0005) 2022; 51 Drummond (10.1016/j.bmcl.2024.129778_b0105) 2020; 60 Jin (10.1016/j.bmcl.2024.129778_b0070) 2020; 63 Zhao (10.1016/j.bmcl.2024.129778_b0020) 2023; 18 Drummond (10.1016/j.bmcl.2024.129778_b0100) 2019; 59 Winter (10.1016/j.bmcl.2024.129778_b0080) 2017; 67 Gao (10.1016/j.bmcl.2024.129778_b0015) 2020; 11 Liang (10.1016/j.bmcl.2024.129778_b0030) 2022; 4 Zhang (10.1016/j.bmcl.2024.129778_b0050) 2022; 58 An (10.1016/j.bmcl.2024.129778_b0040) 2023; 62 Liu (10.1016/j.bmcl.2024.129778_b0075) 2020; 6 Elkinson (10.1016/j.bmcl.2024.129778_b0085) 2013; 73 |
References_xml | – volume: 58 start-page: 10933 year: 2022 end-page: 10936 ident: b0050 publication-title: Chem Commun (Camb) – volume: 68 start-page: 1069 year: 2023 end-page: 1085 ident: b0035 publication-title: Sci Bull (beijing) – volume: 62 start-page: e202306824 year: 2023 ident: b0040 publication-title: Angew Chem Int Ed Engl – volume: 142 start-page: 2193 year: 2020 end-page: 2197 ident: b0060 publication-title: J Am Chem Soc – volume: 11 start-page: 534 year: 2020 end-page: 539 ident: b0015 publication-title: Protein Cell – volume: 5 start-page: 1682 year: 2019 end-page: 1690 ident: b0045 publication-title: ACS Cent Sci – volume: 67 start-page: e19 year: 2017 ident: b0080 publication-title: Mol Cell – volume: 6 start-page: 4966 year: 2015 end-page: 4971 ident: b0095 publication-title: Polym Chem – volume: 63 start-page: 4644 year: 2020 end-page: 4654 ident: b0070 publication-title: J Med Chem – volume: 60 start-page: 5234 year: 2020 end-page: 5254 ident: b0105 publication-title: J Chem Inf Model – volume: 14 start-page: 706 year: 2018 end-page: 714 ident: b0110 publication-title: Nat Chem Biol – volume: 4 start-page: 3809 year: 2022 end-page: 3819 ident: b0030 publication-title: CCS Chemistry – volume: 56 start-page: 5532 year: 2020 end-page: 5535 ident: b0065 publication-title: Chem Commun (Camb) – volume: 6 start-page: 5154 year: 2020 ident: b0075 publication-title: Sci Adv – volume: 81 start-page: e1417 year: 2021 ident: b0010 publication-title: Mol Cell – volume: 9 year: 2021 ident: b0055 publication-title: Front Cell Dev Biol – volume: 73 start-page: 595 year: 2013 end-page: 604 ident: b0085 publication-title: Drugs – volume: 59 start-page: 1634 year: 2019 end-page: 1644 ident: b0100 publication-title: J Chem Inf Model – volume: 18 start-page: e202300530 year: 2023 ident: b0020 publication-title: ChemMedChem – volume: 68 year: 2022 ident: b0090 publication-title: Curr Opin Chem Biol – volume: 51 start-page: 5214 year: 2022 end-page: 5236 ident: b0005 publication-title: Chem Soc Rev – volume: 58 start-page: 10072 year: 2022 end-page: 10075 ident: b0025 publication-title: Chem Commun (Camb) – volume: 51 start-page: 5214 year: 2022 ident: WOS:000807096700001 article-title: PROTACs: past, present and future publication-title: CHEMICAL SOCIETY REVIEWS doi: 10.1039/d2cs00193d – volume: 5 start-page: 1682 year: 2019 ident: WOS:000492698300011 article-title: Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACs publication-title: ACS CENTRAL SCIENCE doi: 10.1021/acscentsci.9b00713 – volume: 18 year: 2023 ident: WOS:001100700000001 article-title: Kinetic Modeling of PROTAC-Induced Protein Degradation publication-title: CHEMMEDCHEM doi: 10.1002/cmdc.202300530 – volume: 6 start-page: 4966 year: 2015 ident: WOS:000357163800013 article-title: Photolabile ROMP gels using ortho-nitrobenzyl functionalized crosslinkers publication-title: POLYMER CHEMISTRY doi: 10.1039/c5py00562k – volume: 81 start-page: 1411 year: 2021 ident: WOS:000637214700010 article-title: TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains publication-title: MOLECULAR CELL doi: 10.1016/j.molcel.2021.01.023 – volume: 58 start-page: 10933 year: 2022 ident: WOS:000850258400001 article-title: Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP- PROTACs) publication-title: CHEMICAL COMMUNICATIONS doi: 10.1039/d2cc03092f – volume: 14 start-page: 706 year: 2018 ident: WOS:000435446600016 article-title: Plasticity in binding confers selectivity in ligand-induced protein degradation publication-title: NATURE CHEMICAL BIOLOGY doi: 10.1038/s41589-018-0055-y – volume: 142 start-page: 2193 year: 2020 ident: WOS:000512222700020 article-title: Optical Control of Small Molecule-Induced Protein Degradation publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.9b12718 – volume: 67 start-page: 5 year: 2017 ident: WOS:000404897300003 article-title: BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment publication-title: MOLECULAR CELL doi: 10.1016/j.molcel.2017.06.004 – volume: 68 start-page: ARTN 102148 year: 2022 ident: WOS:000800101400002 article-title: BET bromodomain inhibitors publication-title: CURRENT OPINION IN CHEMICAL BIOLOGY doi: 10.1016/j.cbpa.2022.102148 – volume: 73 start-page: 595 year: 2013 ident: WOS:000318574200008 article-title: Pomalidomide: First Global Approval publication-title: DRUGS doi: 10.1007/s40265-013-0047-x – volume: 6 start-page: ARTN eaay5154 year: 2020 ident: WOS:000514842000021 article-title: Light-induced control of protein destruction by opto-PROTAC publication-title: SCIENCE ADVANCES doi: 10.1126/sciadv.aay5154 – volume: 68 start-page: 1069 year: 2023 ident: WOS:001019160200001 article-title: Stimuli-activatable PROTACs for precise protein degradation and cancer therapy publication-title: SCIENCE BULLETIN doi: 10.1016/j.scib.2023.04.028 – volume: 62 year: 2023 ident: WOS:001048928600001 article-title: Stimuli-Responsive PROTACs for Controlled Protein Degradation publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION doi: 10.1002/anie.202306824 – volume: 9 start-page: ARTN 678077 year: 2021 ident: WOS:000680366500001 article-title: Light-Controllable PROTACs for Temporospatial Control of Protein Degradation publication-title: FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY doi: 10.3389/fcell.2021.678077 – volume: 63 start-page: 4644 year: 2020 ident: WOS:000535279800017 article-title: Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.9b02058 – volume: 11 start-page: 534 year: 2020 ident: WOS:000535447000001 article-title: FAK-targeting PROTAC as a chemical tool for the investigation of non-enzymatic FAK function in mice publication-title: PROTEIN & CELL doi: 10.1007/s13238-020-00732-8 – volume: 59 start-page: 1634 year: 2019 ident: WOS:000465644500033 article-title: In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application publication-title: JOURNAL OF CHEMICAL INFORMATION AND MODELING doi: 10.1021/acs.jcim.8b00872 – volume: 58 start-page: 10072 year: 2022 ident: WOS:000842605800001 article-title: Reactive oxygen species-responsive Pre-PROTAC for tumor-specific protein degradation publication-title: CHEMICAL COMMUNICATIONS doi: 10.1039/d2cc03367d – volume: 60 start-page: 5234 year: 2020 ident: WOS:000586716900072 article-title: Improved Accuracy for Modeling PROTAC-Mediated Ternary Complex Formation and Targeted Protein Degradation via New In Silico Methodologies publication-title: JOURNAL OF CHEMICAL INFORMATION AND MODELING doi: 10.1021/acs.jcim.0c00897 – volume: 4 start-page: 3809 year: 2022 ident: WOS:000908427000015 article-title: Enzyme-Catalyzed Activation of Pro-PROTAC for Cell-Selective Protein Degradation publication-title: CCS CHEMISTRY doi: 10.31635/ccschem.022.202101529 – volume: 56 start-page: 5532 year: 2020 ident: WOS:000536127800013 article-title: A caged E3 ligase ligand for PROTAC-mediated protein degradation with light publication-title: CHEMICAL COMMUNICATIONS doi: 10.1039/d0cc00523a – volume: 11 start-page: 534 year: 2020 ident: 10.1016/j.bmcl.2024.129778_b0015 publication-title: Protein Cell doi: 10.1007/s13238-020-00732-8 – volume: 6 start-page: 5154 year: 2020 ident: 10.1016/j.bmcl.2024.129778_b0075 publication-title: Sci Adv doi: 10.1126/sciadv.aay5154 – volume: 56 start-page: 5532 year: 2020 ident: 10.1016/j.bmcl.2024.129778_b0065 publication-title: Chem Commun (Camb) doi: 10.1039/D0CC00523A – volume: 63 start-page: 4644 year: 2020 ident: 10.1016/j.bmcl.2024.129778_b0070 publication-title: J Med Chem doi: 10.1021/acs.jmedchem.9b02058 – volume: 51 start-page: 5214 year: 2022 ident: 10.1016/j.bmcl.2024.129778_b0005 publication-title: Chem Soc Rev doi: 10.1039/D2CS00193D – volume: 9 year: 2021 ident: 10.1016/j.bmcl.2024.129778_b0055 publication-title: Front Cell Dev Biol – volume: 59 start-page: 1634 year: 2019 ident: 10.1016/j.bmcl.2024.129778_b0100 publication-title: J Chem Inf Model doi: 10.1021/acs.jcim.8b00872 – volume: 60 start-page: 5234 year: 2020 ident: 10.1016/j.bmcl.2024.129778_b0105 publication-title: J Chem Inf Model doi: 10.1021/acs.jcim.0c00897 – volume: 68 start-page: 1069 year: 2023 ident: 10.1016/j.bmcl.2024.129778_b0035 publication-title: Sci Bull (beijing) doi: 10.1016/j.scib.2023.04.028 – volume: 81 start-page: e1417 year: 2021 ident: 10.1016/j.bmcl.2024.129778_b0010 publication-title: Mol Cell doi: 10.1016/j.molcel.2021.01.023 – volume: 58 start-page: 10933 year: 2022 ident: 10.1016/j.bmcl.2024.129778_b0050 publication-title: Chem Commun (Camb) doi: 10.1039/D2CC03092F – volume: 5 start-page: 1682 year: 2019 ident: 10.1016/j.bmcl.2024.129778_b0045 publication-title: ACS Cent Sci doi: 10.1021/acscentsci.9b00713 – volume: 62 start-page: e202306824 year: 2023 ident: 10.1016/j.bmcl.2024.129778_b0040 publication-title: Angew Chem Int Ed Engl doi: 10.1002/anie.202306824 – volume: 142 start-page: 2193 year: 2020 ident: 10.1016/j.bmcl.2024.129778_b0060 publication-title: J Am Chem Soc doi: 10.1021/jacs.9b12718 – volume: 68 year: 2022 ident: 10.1016/j.bmcl.2024.129778_b0090 publication-title: Curr Opin Chem Biol doi: 10.1016/j.cbpa.2022.102148 – volume: 18 start-page: e202300530 year: 2023 ident: 10.1016/j.bmcl.2024.129778_b0020 publication-title: ChemMedChem doi: 10.1002/cmdc.202300530 – volume: 67 start-page: e19 year: 2017 ident: 10.1016/j.bmcl.2024.129778_b0080 publication-title: Mol Cell doi: 10.1016/j.molcel.2017.06.004 – volume: 73 start-page: 595 year: 2013 ident: 10.1016/j.bmcl.2024.129778_b0085 publication-title: Drugs doi: 10.1007/s40265-013-0047-x – volume: 58 start-page: 10072 year: 2022 ident: 10.1016/j.bmcl.2024.129778_b0025 publication-title: Chem Commun (Camb) doi: 10.1039/D2CC03367D – volume: 6 start-page: 4966 year: 2015 ident: 10.1016/j.bmcl.2024.129778_b0095 publication-title: Polym Chem doi: 10.1039/C5PY00562K – volume: 14 start-page: 706 year: 2018 ident: 10.1016/j.bmcl.2024.129778_b0110 publication-title: Nat Chem Biol doi: 10.1038/s41589-018-0055-y – volume: 4 start-page: 3809 year: 2022 ident: 10.1016/j.bmcl.2024.129778_b0030 publication-title: CCS Chemistry doi: 10.31635/ccschem.022.202101529 |
SSID | ssj0014044 |
Score | 2.444227 |
Snippet | [Display omitted]
PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin–proteasome... PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin -proteasome system. These... PROTACs (Proteolysis targeting chimeras) are chimeric molecules designed to induce targeted protein degradation via the ubiquitin-proteasome system. These... |
Source | Web of Science |
SourceID | proquest pubmed crossref webofscience elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 129778 |
SubjectTerms | Chemical tool Chemistry Chemistry, Medicinal Chemistry, Organic Life Sciences & Biomedicine Pharmacology & Pharmacy Photo-caged group Photocleavable linker Physical Sciences PROTAC Science & Technology Turn-off type |
Title | Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation |
URI | https://dx.doi.org/10.1016/j.bmcl.2024.129778 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=001238771800001 https://www.ncbi.nlm.nih.gov/pubmed/38702019 https://www.proquest.com/docview/3050939919 |
Volume | 107 |
WOS | 001238771800001 |
WOSCitedRecordID | wos001238771800001 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9UwFD6MCeqL6J0_rtMRYfgi2V2bpGl8K8VxVTaHbnDxpSRtwq7ctWPrBr74t3uSphfFIeJjm6SkOck5X3JOvgOw26TO5Mw4KkXtKM8Vp2o_NzRFW5wJm2gdGPgOj7L5Kf-wEIsNKMe7MD6sMur-QacHbR3fzOJozi6Wy9kXD77x2wsfBZnk-wt_g51LP8v3fqzDPDx7TKCQwsrU144XZ4YYL3Nee_dDyvfQ7Emfau124_Qn-LzVTgWbdPAQHkQwSYqhv49gw7YT2Cpa3EiffyevSQjvDOfmE7hXjqndJnD3MHrUt-Dr8VnXd_RySElvG3L8-dNJUV69JQVpuxu7In3XrQhCWxJZrFYkhreTzpEhkBybBb6HZUsaTz4x5Gl6DKcH707KOY35FmjNJOspt7i8pc0Sk_FGZyhBx2ulamG5k5rh6nVO5oh4WCa0VpI5n7na5FbVTunGsCew2XatfQbEWF7blDuumeJOGZU5wSRuepM0sbXQU3gzDnR1MdBqVGO82bfKi6XyYqkGsUxBjLKofpscFer9v7Z7NQquwhH2rhDd2u76qmKe9gaxWaKm8HSQ6LofDFUYwiIs2f1VxOvyAENziUY9uEamkPxLtTJSrnuqgf75f_7QNtz3T_5sOREvYLO_vLYvERT1ZifM-h24U7z_OD_6CerpCS4 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NTmK8oNHxozDASBMvKLSJ7STeWxQxdWwtE3RSxYtlJ7Yo6pJpy5D473dOnArEhBCvcRw5_uK7L77zdwAHZWR1SrUNEl7YgKWCBWKS6iBCXxxzEyrVKvDN5vH0nH1c8uUW5P1ZGJdW6W1_Z9Nba-2vjP1sji9Xq_EXR77x2UuXBRmmk-U92HbqVHwA29nxyXS-CSawSVvT1d0fuA7-7EyX5qUvCheBiNh79HyJq7Z2t3_6k3_e6apat3S0Cw89nyRZN-RHsGWqIexlFf5LX_wkb0mb4dlunQ9hJ--ruw3h_swH1ffg69m3uqmDq64qvSnJ2edPiyy_PiQZqeofZk2aul4TZLfEC1mtic9wJ7UlXS45dmslH1YVKZ3-RFeq6TGcH31Y5NPAl1wICprQJmAGV3hi4lDHrFQxgmhZIUTBDbOJoriArU1SJD005kqJhFpXvFqnRhRWqFLTJzCo6so8A6INK0zELFNUMCu0iC2nCf73hlFoCq5G8K6faHnZKWvIPuXsu3SwSAeL7GAZAe-xkL99HxJN_1_7vemBkzjDLhqiKlPfXEvqlG-QnoViBE87RDfjoGjFkBlhy8GvEG_aWyaaJujX2-jICMJ_uS33qutObaB5_p8v9Bp2povZqTw9np-8gAeuxW01h3wfBs3VjXmJHKnRr_wauAX9sgvf |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Photo-regulated+PROTACs%3A+A+novel+tool+for+temporal+control+of+targeted+protein+degradation&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Xu%2C+Hanqiao&rft.au=Ohoka%2C+Nobumichi&rft.au=Yokoo%2C+Hidetomo&rft.au=Demizu%2C+Yosuke&rft.date=2024-07-15&rft.pub=Elsevier&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=107&rft_id=info:doi/10.1016%2Fj.bmcl.2024.129778&rft_id=info%3Apmid%2F38702019&rft.externalDBID=n%2Fa&rft.externalDocID=001238771800001 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon |